Literature DB >> 8703222

Hypoxic-ischemic encephalopathy in areas of primary myelination: a neuroimaging and PET study.

B Azzarelli1, K S Caldemeyer, J P Phillips, W E DeMyer.   

Abstract

The stage of regional structural and biochemical development of the central nervous system appears as a critical factor determining the distribution of hypoxic-ischemic lesions during the perinatal period. We describe the brain lesions in 12 patients who suffered hypoxia-ischemia during the perinatal period. The gestational age ranged from 35 to 42 weeks and the age at death from 2 to 16 weeks. There is one patient alive at age 18 years and a second patient at age 1 year. The cerebral cortical damage is mainly restricted to areas of primary myelination and adjacent subcortical white matter. In addition, there is thalamic, basal ganglia, brainstem, and spinal cord damage. It is postulated that selective damage occurs in those areas which at the moment of the hypoxic-ischemic insult had achieved higher rates of oxygen-glucose utilization. This hypothesis is supported by studies utilizing positron emission tomography which indicates that glucose utilization in the normal human neonatal brain follows a phylogenetic order. Regions that achieved higher levels of glucose consumption are those that suffered the brunt of the damage in our term neonates.

Entities:  

Mesh:

Year:  1996        PMID: 8703222     DOI: 10.1016/0887-8994(96)00010-0

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  11 in total

1.  A neuroradiology self-assessment module for use in emergency radiology.

Authors:  James Provenzale
Journal:  Emerg Radiol       Date:  2008-07-19

2.  The role of positron emission tomography/CT in hypoxic ischaemic encephalopathy in children.

Authors:  Zehra Pinar Koc; Tansel Ansal Balci; Saadet Akarsu; Kemal Unal
Journal:  BMJ Case Rep       Date:  2013-01-02

3.  Sonography, CT, and MR imaging: a prospective comparison of neonates with suspected intracranial ischemia and hemorrhage.

Authors:  F G Blankenberg; N N Loh; P Bracci; H E D'Arceuil; W D Rhine; A M Norbash; B Lane; A Berg; B Person; M Coutant; D R Enzmann
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

4.  Neonatal hypoxic-ischemic encephalopathy: detection with diffusion-weighted MR imaging.

Authors:  K P Forbes; J G Pipe; R Bird
Journal:  AJNR Am J Neuroradiol       Date:  2000-09       Impact factor: 3.825

5.  Proton spectroscopy and diffusion imaging on the first day of life after perinatal asphyxia: preliminary report.

Authors:  A J Barkovich; K D Westmark; H S Bedi; J C Partridge; D M Ferriero; D B Vigneron
Journal:  AJNR Am J Neuroradiol       Date:  2001-10       Impact factor: 3.825

Review 6.  Magnetic resonance imaging of the neonatal brain.

Authors:  Ariel Prager; Sudipta Roychowdhury
Journal:  Indian J Pediatr       Date:  2007-02       Impact factor: 1.967

7.  Diffusion-weighted MR imaging in the early diagnosis of periventricular leukomalacia.

Authors:  Alessandro Bozzao; Ambrogio Di Paolo; Clarissa Mazzoleni; Fabrizio Fasoli; Alessandra Simonetti; Luigi Maria Fantozzi; Roberto Floris
Journal:  Eur Radiol       Date:  2003-02-07       Impact factor: 5.315

8.  Cerebellar vermian atrophy after neonatal hypoxic-ischemic encephalopathy.

Authors:  Michael A Sargent; Kenneth J Poskitt; Elke H Roland; Alan Hill; Glenda Hendson
Journal:  AJNR Am J Neuroradiol       Date:  2004 Jun-Jul       Impact factor: 3.825

9.  Cerebral Blood Flow of the Neonatal Brain after Hypoxic-Ischemic Injury.

Authors:  Luis Octavio Tierradentro-García; Sandra Saade-Lemus; Colbey Freeman; Matthew Kirschen; Hao Huang; Arastoo Vossough; Misun Hwang
Journal:  Am J Perinatol       Date:  2021-07-05       Impact factor: 1.862

10.  Nesting Environment Provides Sex-Specific Neuroprotection in a Rat Model of Neonatal Hypoxic-Ischemic Injury.

Authors:  Briana Mason; L G Rollins; Evans Asumadu; Christina Cange; Najah Walton; S Tiffany Donaldson
Journal:  Front Behav Neurosci       Date:  2018-10-02       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.